Webinar · March 2025
Exploring emerging clinical trial hubs in EECCA: webinar recap
Our expert panel provided a comprehensive examination of the regulatory environment, operational challenges, and strategic opportunities in the EECCA region — covering Eastern Europe, Caucasus and Central Asia.
Key takeaways
- The EECCA region continues to make significant progress in harmonising regulatory frameworks, though each country presents unique challenges and timelines.
- The clinical trial infrastructure across EECCA is expanding, with increasing numbers of qualified sites, experienced investigators, and improved patient recruitment capabilities.
- Success in the region requires deep understanding of country-specific regulations, cultural sensitivity, strong site selection, and investment in long-term partnerships with experienced local teams.
Our distinguished panel
- Vadym Kutsenok — Director, Country Site Activation Head for Ukraine & Hungary, IQVIA
- Tamar Bolkvadze — Country MD, Georgia, OXIMIO
- Alex Shakhov — Sr. Manager Clinical Trial Liaison, Global Site Management, REGENERON
- Olga Vizgalova — Regional Director CEE, OXIMIO
- Pavlo Garkaviy — Senior International Medical Director, NOVO NORDISK
- Dr. Manthinda Hettiarachchi — Senior Project Director & Global Therapeutic Area Head, GEORGE CLINICAL
Expertly moderated by Diana Matiashvili, Founder & CEO, Paspigioni.
The opportunity
The EECCA region represents a significant opportunity for clinical research expansion. As these markets continue to mature, sponsors who invest in understanding the landscape, building strong partnerships, and approaching the region strategically will be well-positioned for success.